Aims: This study was undertaken to determine the prevalence of active epilepsy, assess the sociodemographic profile, and psychological aspects of epilepsy in the Jaipur district of Rajasthan, India. Methods: We conducted a community-based, cross-sectional observational study covering both rural (n = 165,660) and urban (n = 179,142) populations of Jaipur district using a house-to-house survey. An adapted, pre-designed World Health Organization screening questionnaire was used to identify the cases. Those confirmed by neurologists as true seizures were included in the study. Cases were classified as per the International League against Epilepsy recommendation. Global Mental Health Assessment Tool electronic questionnaire was used to analyze psychological aspects of cases. The caregivers of the patients participated in the knowledge, attitude, and practice (KAP) survey. Results: A total of 380 patients (258 men, 122 women) were identified with active epilepsy. The estimated prevalence of active epilepsy was 1.1/1,000 population and 71% of cases belonged to low socioeconomic classes. Primary treatment gap was documented in 18.8% of cases in our study, 38% of cases were non-compliant to treatment with poorer compliance in those on pol-therapy, 76% had some psychiatric disorder, anxiety and depression being the commonest, and positive family history of epilepsy was found in 4.7%. KAP survey revealed that only 15% of the respondents believed that epilepsy is non-curable, 74% denied its infectious nature, 26% believed that epilepsy occurs due to past sins, and 81% said that they would not marry persons with epilepsy. Conclusion: A relatively low prevalence (1.1/1,000) of active epilepsy and a smaller primary treatment gap (18.8%) was found in our study population. Almost three-fourth of cases had an associated psychological problem, Though caregivers were aware of the nature of disease, majority would not prefer to marry a person suffering from epilepsy.

Keywords:
Epilepsy, Prevalence, Seizure, India, Knowledge attitude, Jaipur, Rajasthan
1.
Mbuba CK, Ngugi AK, Newton CR, Carter JA: The epilepsy treatment gap in developing countries: a systematic review of the magnitude, causes, and intervention strategies. Epilepsia 2008; 49: 1491–1503.
2.
WHO: World Health Organization (WHO) Factsheet: Epilepsy 2015 (cited May 1, 2015). http://www.who.int/mediacentre/factsheets/fs999/en/.
3.
Ngugi AK, Kariuki SM, Bottomley C, Kleinschmidt I, Sander JW, Newton CR: Incidence of epilepsy: a systematic review and meta-analysis. Neurology 2011; 77: 1005–1012.
4.
Ngugi AK, Bottomley C, Kleinschmidt I, Sander JW, Newton CR: Estimation of the burden of active and life-time epilepsy: a meta-analytic approach. Epilepsia 2010; 51: 883–890.
5.
Sridharan R, Murthy BN: Prevalence and pattern of epilepsy in India. Epilepsia 1999; 40: 631–636.
6.
Gourie-Devi M, Gururaj G, Satishchandra P, Subbakrishna DK: Prevalence of neurological disorders in Bangalore, India: a community-based study with a comparison between urban and rural areas. Neuroepidemiology 2004; 23: 261–268.
7.
Sridharan R: Epidemiology of epilepsy. Curr Sci 2002; 82: 664–670.
8.
Goel D, Agarwal A, Dhanai JS, Semval VD, Mehrotra V, Saxena V, et al: Comprehensive rural epilepsy surveillance programme in Uttarakhand state of India. Neurol India 2009; 57: 355–356.
9.
Radhakrishnan K, Pandian JD, Santhoshkumar T, Thomas SV, Deetha TD, Sarma PS, et al: Prevalence, knowledge, attitude, and practice of epilepsy in Kerala, South India. Epilepsia 2000; 41: 1027–1035.
10.
Bharucha NE, Bharucha EP, Bharucha AE, Bhise AV, Schoenberg BS: Prevalence of epilepsy in the Parsi community of Bombay. Epilepsia 1988; 29: 111–115.
11.
Banerjee TK, Ray BK, Das SK, Hazra A, Ghosal MK, Chaudhuri A, et al: A longitudinal study of epilepsy in Kolkata, India. Epilepsia 2010; 51: 2384–2391.
12.
MK I: Collaborative Study of Severe Mental Morbidity, 1987.
13.
Tandon P: Epilepsy in India: Report Based on a Multicentric Study on Epidemiology of Epilepsy Carried Out as a PL 480 Funded Project of the ICMR, 1989.
14.
Bharucha NE: Epidemiology of Epilepsy in India. Epilepsia 2003; 44(suppl 1):9–11.
15.
Placencia M, Sander JW, Shorvon SD, Ellison RH, Cascante SM: Validation of a screening questionnaire for the detection of epileptic seizures in epidemiological studies. Brain 1992; 115(pt 3):783–794.
16.
Prosad BG: Changes proposed in the social classification of Indian families. J Indian Med Assoc 1970; 55: 198–199.
17.
Blume WT, Luders HO, Mizrahi E, Tassinari C, van Emde Boas W, Engel J Jr: Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology. Epilepsia 2001; 42: 1212–1218.
18.
ILAE Commission Report. The epidemiology of the epilepsies: future directions. International league against epilepsy. Epilepsia 1997; 38: 614–618.
19.
Sharma VK, Lepping P, Cummins AG, Copeland JR, Parhee R, Mottram P: The global mental health assessment tool–primary care version (GMHAT/PC). Development, reliability and validity. World psychiatry 2004; 3: 115–119.
20.
Krentel A, Fischer P, Manoempil P, Supali T, Servais G, Ruckert P: Using knowledge, attitudes and practice (KAP) surveys on lymphatic filariasis to prepare a health promotion campaign for mass drug administration in Alor District, Indonesia. Trop Med Int Health 2006; 11: 1731–1740.
21.
Ebrahimi H, Shafa M, Hakimzadeh Asl S : Prevalence of active epilepsy in Kerman, Iran: a house based survey. Acta Neurol Taiwan 2012;21:115–124.
22.
Benamer HT, Grosset DG: A systematic -review of the epidemiology of epilepsy in Arab countries. Epilepsia 2009; 50: 2301–2304.
23.
Shakirullah S, Ali N, khan A, Nabi M: The Prevalence, Incidence and Etiology of Epilepsy. Int J Clin and Exp Neurol 2014; 2: 29–39.
24.
Koul R, Razdan S, Motta A: Prevalence and pattern of epilepsy (Lath/Mirgi/Laran) in rural Kashmir, India. Epilepsia 1988; 29: 116–122.
25.
Mani KS: Epidemiology of epilepsy in Karnataka, India. Neurosci Today 1997; 1: 167–174.
26.
Shetty PH, Naik RK, Saroja A, Punith K: Quality of life in patients with epilepsy in India. J Neurosci Rural Pract 2011; 2: 33–38.
27.
Ashwin M, Rakesh P, Pricilla RA, Manjunath K, Jacob K, Prasad J. Determinants of quality of life among people with epilepsy attending a secondary care rural hospital in south India. J Neurosci Rural Pract 2013; 4(suppl 1):S62–S66.
28.
Myeong-Kyu K: Marital prospects of people with epilepsy among Asians. Neurol Asia 2007; 12: 13–14.
29.
Carpio A, Hauser WA: Epilepsy in the developing world. Curr Neurol Neurosci Rep 2009; 9: 319–326.
30.
Singhi P: Infectious causes of seizures and epilepsy in the developing world. Dev Med Child Neurol 2011; 53: 600–609.
31.
Danesi MA, Odusote KA, Roberts OO, Adu EO: Social problems of adolescent and adult epileptics in a developing country, as seen in Lagos, Nigeria. Epilepsia 1981; 22: 689–696.
32.
Gursahani R, Gupta N: The adolescent or adult with generalized tonic-clonic seizures. Ann Indian Acad Neurol 2012; 15: 81–88.
33.
Pal SK, Sharma K, Prabhakar S, Pathak A: Neuroepidemiology of Epilepsy in Northwest India. Ann Neurosci 2010; 17: 160–166.
34.
Goel D, Dhanai JS, Agarwal A, Mehlotra V, Saxena V: Knowledge, attitude and practice of epilepsy in Uttarakhand, India. Ann Indian Acad Neurol 2011; 14: 116–119.
35.
Gourie-Devi M, Singh V, Bala K: Knowledge, attitude and practices among patients of epilepsy attending tertiary hospital in Delhi, India and a review of -Indian studies. Neurol Asia 2010; 15: 255–232.
36.
Pal DK, Pong AW, Chung WK: Genetic evaluation and counseling for epilepsy. Nat Rev Neurol 2010; 6: 445–453.
37.
Lacey CJ, Salzberg MR, D’Souza WJ: Risk factors for depression in community-treated epilepsy: systematic review. Epilepsy Behav 2015; 43: 1–7.
38.
Clancy MJ, Clarke MC, Connor DJ, Cannon M, Cotter DR. The prevalence of psychosis in epilepsy; a systematic review and meta-analysis. BMC Psychiatry 2014; 14: 75.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.